Thermo Fisher Scientific Inc., founded in 2006 and headquartered in Waltham, Massachusetts, is a global leader in serving science. The company provides a wide range of analytical instruments, reagents, and consumables, as well as software and services for laboratories and medical facilities, enhancing research and clinical diagnostics.
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Since its inception, Thermo Fisher has actively issued bonds to fund strategic acquisitions and enhance its capital structure. Notable issuances include a substantial $2.5 billion bond offering in 2020 to finance the acquisition of PPD, which bolstered its position in the life sciences market. As of October 2023, the company’s bonds yield around 3.2%, which is competitive within the industry, and offer features like call options and fixed rates, reflecting investor confidence in Thermo Fisher’s robust financial health and growth trajectory.